These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. E 3040. Drugs R D; 1999 Mar; 1(3):256-7. PubMed ID: 10566039 [No Abstract] [Full Text] [Related]
9. Inflammatory bowel disorders. Summary and table. Wagetaff A; Elkinson S Drugs R D; 1999 Mar; 1(3):245-50. PubMed ID: 10566036 [No Abstract] [Full Text] [Related]
10. [Anti-inflammatory properties of interleukin-10 in human Crohn's disease: much to learn, much to explore]. Stallmach A; Schmidt C; Marth T Z Gastroenterol; 2002 Jun; 40(6):475-7. PubMed ID: 12055668 [No Abstract] [Full Text] [Related]
11. Guidelines for the management of inflammatory bowel disease in adults. Carter MJ; Lobo AJ; Travis SP; Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569 [No Abstract] [Full Text] [Related]
14. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature. Peyrin-Biroulet L Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972 [No Abstract] [Full Text] [Related]
15. Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment. Quetglas EG; Armuzzi A; Wigge S; Fiorino G; Barnscheid L; Froelich M; Danese S Eur J Clin Pharmacol; 2015 Jul; 71(7):773-99. PubMed ID: 26008212 [TBL] [Abstract][Full Text] [Related]
16. [Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases]. Wittig BM; Zeitz M Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S52-8. PubMed ID: 11450615 [No Abstract] [Full Text] [Related]
17. Therapeutic implications of interleukin-10 in inflammatory bowel disease. Shirachi A Kurume Med J; 1998; 45(1):63-7. PubMed ID: 9658753 [TBL] [Abstract][Full Text] [Related]
18. Novel pharmacological therapies for irritable bowel syndrome. Corsetti M; Whorwell P Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):807-15. PubMed ID: 26907518 [TBL] [Abstract][Full Text] [Related]